NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute
    India

    Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute

    Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute
    Written by Siddhant Pandey
    Aug 30, 2020, 07:32 pm 2 min read
    Bangladesh's Beximco enters COVID-19 vaccine deal with India's Serum Institute

    One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, has announced that it will invest in the Serum Institute of India (SII) for the development of a coronavirus vaccine. The deal is aimed at ensuring that Bangladesh has access to the vaccine. SII is the largest vaccine manufacturer and is conducting trials for three potential coronavirus vaccines, including the Oxford University-AstraZeneca's AZD1222 vaccine.

    SII will prioritize Bangladesh to send agreed quantity of doses

    Beximco Pharmaceuticals announced in a statement Friday that it will invest in SII. Although the statement did not disclose the size of the investment, it said the amount will depend on regulatory approvals, SII's production capacity, and earlier commitments to other countries. After the vaccine receives all necessary regulatory approvals, SII will prioritize Bangladesh to send an agreed quantity of doses, the statement added.

    'Sign of the depth of relationship between two countries'

    Speaking to NDTV, Shayan F Rahman, Principal of Beximco Pharmaceuticals, said, "We at Beximco have been able to guarantee that once the vaccine is globally registered, Bangladesh will be one of the first countries to use it." Rahman added, "It is a sign of the depth of relationship not just between Serum India and Beximco, but also between the two countries."

    'Landmark agreement reflects deep-rooted desire for India-Bangladesh collaboration'

    Rahman and SII CEO Adar Poonawalla said in a joint statement, "This landmark agreement reflects the deep-rooted desire for collaboration between the two countries and as representatives of the two nations, we can go a long way towards helping to mitigate the health crisis..."

    India's Foreign Secretary met Bangladeshi PM recently

    Earlier this month, India's Foreign Secretary Harsh Shringla had met Bangladesh Prime Minister Sheikh Hasina in Dhaka. Shringla had said, "India produces 60% of the world's vaccines. When the vaccine is produced, it goes without saying that our closest neighbors, friends, partners, and other countries will be part of that." Separately, Bangladesh has also approved the late-stage trials of China's Sinovac Biotech's vaccine candidate.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Bangladesh
    Vaccine
    Coronavirus
    Serum Institute of India

    Latest

    Ajay Devgn's birthday special: Bollywood's undisputed action king Ajay Devgn
    Petra Kvitova wins the 2023 Miami Open: Key stats Petra Kvitova
    Happy birthday, Kapil Sharma: Tracing actor-comedian's phenomenal journey in showbiz Kapil Sharma
    #NewsBytesExplainer: Why celebrities often perform during IPL opening, closing ceremonies Indian Premier League (IPL)

    Bangladesh

    PM Modi, Sheikh Hasina to inaugurate India-Bangladesh friendship pipeline today Narendra Modi
    Bangladesh: 15 dead, 100+ injured in Dhaka building blast Dhaka
    Why did Bangladesh ban Hansal Mehta's 'Faraaz' Bollywood
    International Mother Language Day 2023: History, theme, significance, and more UNESCO

    Vaccine

    Gurugram: Woman confined herself, son for 3 years fearing COVID-19 Gurugram
    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    US approves world's first vaccine for honey bees United States of America
    Delhi: Government centers run out of free COVID-19 booster vaccine Delhi

    Coronavirus

    UP: CM Yogi Adityanath meets Team 9 amid COVID-19 resurgence COVID-19
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months COVID-19
    PM Modi to hold high-level meeting amid rising COVID-19 cases Narendra Modi
    India reports highest daily COVID-19 cases in 2023: Check tally COVID-19 India

    Serum Institute of India

    Serum Institute seeks DCGI's approval for Covovax as booster dose Drugs Controller General of India
    India's 100 richest amassed $25bn more wealth in 2022: Forbes Gautam Adani
    Covishield manufacturer SII duped of Rs. 1 crore, 7 arrested Pune
    Covishield death: Bombay HC notice to Centre, Serum Institute, DCGI Bombay High Court

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023